Bevacizumab Biosimilars Market

Avastin® (Bevacizumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive / Terminated / Withdrawn Biosimilars, Industry / Non-Industry Partnerships

  • Lowest Price Guaranteed

  • Pages
    91

  • Last Updated
    July 2026

  • View Count
    17459

Table of Contents

Excel Deliverable
1. Dashboard
A. Overall Summary
B. Approved & Launched Biosimilars
C. Investigational & Research Use Biosimilars
D. Inactive / Terminated / Withdrawn Biosimilars
E. Commercialization Partners
F. Partnerships & Collaborations
G. Individual Biosimilar Details

2. Data Table 1: Summary

3. Data Table 2: Approved and Launched Products

4. Data Table 3: Investigational and Research Use Products

5. Data Table 4: Commercialization Partners

6. Data Table 5: Partnerships

7. Appendix I: Pivot Tables

PowerPoint Deliverable
1. Context

2. Executive Summary

3. Overview of Biosimilars4. About the Reference Product

5. Contemporary Pipeline Analysis
5.1. Approved / Launched Products
5.2. Investigational and Research Use Products
5.3. Inactive / Terminated / Withdrawn Products
5.4. Commercialization Partners

6. Analysis of Partnerships

7. Company Profiles
7.1. Company A (Chicago, USA)
7.2. Company B (Mumbai, India)
7.3. Company C (California, USA)
7.4. Company D (Tehran, Iran)
7.5. Company E (Saint Petersburg, Russia)
7.6. Company F (Bangalore, India)
7.7. Company G (Ahmedabad, India)
7.8. Company H (Cambridge, UK)
7.9. Company I (Hyderabad, India)
7.10. Company J (Pune, India)
7.11. Company K (Hyderabad, India)
7.12. Company L (Suzhou, China)
7.13. Company M (Ahmedabad, India)
7.14. Company N (Buenos Aires, Argentina)
7.15. Company O (Mumbai, India)
7.16. Company P (Madrid, Spain)
7.17. Company Q (New York, USA)
7.18. Company R (Jinan, China)
7.19. Company S (Navi Mumbai, India)
7.20. Company T (Incheon, South Korea)
7.21. Company U (Shanghai, China)

8. Appendices

List of Companies

The following companies and organizations have been mentioned in the report.

  1. 3SBio
  2. Abbott Laboratories
  3. Alkem Laboratories
  4. Allergan
  5. Amgen 
  6. Amneal Pharmaceuticals
  7. Apobiologix (formely known as Apotex)
  8. AryoGen Pharmed
  9. Aurobindo Pharma
  10. Axis Biotec Brasil
  11. BeiGene
  12. Beijing Eastern Biotech
  13. Bio?Thera Solutions
  14. Biocad
  15. BIOCND
  16. Biocon
  17. Biomm
  18. Biovision
  19. Bioxpress Therapeutics
  20. Boehringer Inglheim
  21. Cadila Pharmaceuticals
  22. Celltrion
  23. Centus Biotherapeutics
  24. Cipla
  25. Coherus
  26. Coherus Biosciences
  27. Creative Biolabs
  28. Daichi Sankyo
  29. Dr Reddy’s Laboratories
  30. Emcure
  31. Essex
  32. Etana Biotechnologies
  33. GMS Tenshi
  34. Hetero Healthcare
  35. Huahai Pharmaceutical
  36. Huons
  37. Ichor Bio
  38. Innovent Biologics
  39. Intas Pharmaceuticals
  40. Ipca Laboratories
  41. Laboratorio Elea
  42. Lee's Pharmaceutical
  43. Liomont
  44. Lupin
  45. Mabworks
  46. mAbxience
  47. Merck KGaA
  48. Mylan
  49. Oncobiologics (Now Outlook Therapeutics)
  50. Pfizer
  51. PharmaPraxis
  52. PlantForm 
  53. Prestige Biopharma 
  54. Qilu Pharmaceutical
  55. R & D Systems
  56. Real Gene
  57. Reliance Life Sciences
  58. Samsung Bioepis
  59. Shanghai Henlius biotech
  60. Simcere
  61. SinoCellTech
  62. Sydlabs
  63. TheraMabs
  64. TL Pharmaceuticals
  65. TOT Biopharm
  66. Zentiva

Source 1: www.ncbi.nlm.nih.gov/pmc/articles/PMC379333/#:~:text=Ferrara's%20history%20with%20Avastin%20began,growth%20%E2%80%94%20that%20protein%20was%20VEGF.
Source 2: www.medicalnewstoday.com/articles/avastin#about
Source 3: www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/avastin-bevacizumab-information#:~:text=Avastin%20was%20first%20approved%20in,under%20the%20accelerated%20approval%20program.
Source 4: www.ncbi.nlm.nih.gov/pmc/articles/PMC3744967/#:~:text=On%20November%2018%2C%202011%2C%20the,the%20treatment%20of%20breast%20cancer.

Download Free Sample